Ayurveda Offers Natural Solution for Irregular Periods

Dr. Debabrata Sen, Ayurvedacharya and Founder, Parampara Ayurvedic Wellness Centre | Tuesday, 22 July 2025

Hailing from one of Eastern India’s oldest surviving Ayurvedic families, Dr. Debabrata Sen’s legacy is steeped in history. His forefathers were renowned royal physicians, serving influential families such as the Tagores and the household of Acharya Prafulla Chandra Roy. With a Bachelor of Ayurvedic Medicine and Surgery from the University of Calcutta, he continues this distinguished tradition with a mission: to protect and promote Ayurveda as a true system of medical science, free from the clutches of quackery and commercialization.

Ayurveda is not just a wellness fad — it is a Swadeshi science rooted in centuries of clinical practice,” he often says. Dr. Sen is especially vocal against the misuse of Ayurvedic terminology by unqualified beauticians and self-proclaimed healers. For him, Ayurveda is not a trend, but a disciplined and holistic approach to healing.

He has been in the forefront of reviving the Ayurveda practice through his relentless outreach among the masses; he is modern India’s face of Ayurveda.

In a world increasingly drawn to natural wellness solutions, Dr. Debabrata Sen emerges as a commanding voice of authenticity and integrity in the field of Ayurveda. An Ayurvedacharya with a deep-rooted lineage and a modern scientific outlook, Dr. Sen has committed his life to preserving India’s rich Ayurvedic heritage while bringing it into alignment with contemporary medical research.

Speaking on the issue of Irregular periods, Dr Sen says,

“Irregular periods are more than just a minor inconvenience — they are often signals of deeper imbalances within the body. In my practice at Parampara Ayurvedic Wellness Centre, I have seen countless women struggle with erratic menstrual cycles caused by hormonal imbalances, Polycystic Ovary Syndrome (PCOS), stress, poor digestion, and even early signs of menopause. While modern medicine offers quick fixes, Ayurveda takes a deeper, natural route—addressing the root causes rather than suppressing the symptoms.

Ayurveda, the timeless Indian system of holistic healing, believes that a woman’s menstrual cycle is governed by the tridoshasVata, Pitta, and Kapha. Any disruption in their delicate balance can manifest as irregular cycles, painful menstruation, mood disturbances, and fertility issues. A healthy cycle, according to Ayurvedic texts, is a sign of overall vitality and balance.

Understanding Irregular Periods & PCOS in Ayurveda

One of the most common modern causes of irregular periods is PCOS (Polycystic Ovary Syndrome)—a condition that now affects 1 in 5 women in India. From an Ayurvedic perspective, PCOS is typically considered a Kapha-Vata disorder, where excess Kapha leads to accumulation and cyst formation, and Vata aggravation disrupts the flow and timing of the cycle.

Symptoms such as weight gain, acne, facial hair, mood swings, and infertility are seen as a result of ama (toxins), poor agni (digestive fire), and doshic imbalance. The key lies in correcting these internal imbalances through holistic measures.

Ayurvedic Solutions for Regular Cycles

In Ayurveda, no two individuals are a like — every woman’s treatment is personalized. However, certain foundational principles remain universal:

1. Herbal Remedies

Some powerful herbs that support hormonal balance and regular ovulation include:

  • Ashoka (Saraca indica): Known as a uterine tonic, Ashoka helps balance estrogen levels and supports proper endometrial function.
  • Shatavari (Asparagus racemosus): A renowned adaptogen and Rasayana herb, it strengthens the female reproductive system, stabilizes hormones, and boosts fertility.
  • Lodhra (Symplocos racemosa): Effective in managing excessive bleeding, inflammation, and hormonal imbalances, especially in PCOS.
  • Triphala: Improves digestion and helps detoxify the body, indirectly benefiting menstrual regulation.

Studies have shown that these herbs help regulate the hypothalamic-pituitary-ovarian (HPO) axis, promoting ovulation and reducing symptoms like acne and hirsutism.

2. Diet and Nutrition

A sattvic diet, which is fresh, plant-based, and seasonal, can drastically improve menstrual health. Foods to focus on include:

  • Warm, cooked vegetables and whole grains like red rice and millets
  • Ghee, soaked almonds, sesame seeds for healthy fats and calcium
  • Herbal teas with fennel, cinnamon, or ginger to boost digestion and reduce cramps

Avoid cold, processed, and sugary foods that aggravate Kapha and cause ama build-up.

3. Lifestyle & Yoga

  • Daily routines (Dinacharya): Waking up early, oil massage (Abhyanga), and maintaining a fixed meal and sleep schedule supports hormonal rhythm.
  • Stress reduction: Pranayama, meditation, and mindfulness help calm Vata and reduce cortisol levels, which are often elevated in PCOS.
  • Yoga Asanas like Baddha Konasana (Butterfly Pose), Bhujangasana (Cobra Pose), and Malasana (Garland Pose) are excellent for reproductive organ stimulation and pelvic circulation.

Long-Term Benefits of Ayurvedic Management

Women who commit to Ayurvedic routines report improvements within 3 to 6 cycles. Some of the common benefits include:

  • More regular and less painful periods
  • Improved skin health and reduced acne
  • Better energy and emotional stability
  • Enhanced fertility and reduced dependency on hormonal medications

Most importantly, these remedies come without side effects — as Ayurveda works with the body, not against it.

Ayurveda is not just a wellness fad — it is a Swadeshi science rooted in centuries of clinical practice,” he often says. Dr. Sen is especially vocal against the misuse of Ayurvedic terminology by unqualified beauticians and self-proclaimed healers. For him, Ayurveda is not a trend, but a disciplined and holistic approach to healing.”

Final Words

“In my years of practice, I’ve seen young girls, working professionals, and even post-menopausal women reclaim their health through Ayurveda. Irregular periods are not a life sentence — they are a signal. Ayurveda teaches us to listen to the body, restore internal balance, and let healing unfold naturally.”

About the Author:

Dr. Debabrata Sen is the Founder of Parampara Ayurveda, an Ayurvedacharya, educator, and global advocate of classical Indian healing traditions. With decades of clinical experience, he is known for making Ayurveda accessible, personalised, and practical in the modern world.

  1. Follow Dr. Sen on Instagram @drdebabratasenofficial or visit parampara.online for consultations and insights.

on the deck

Most Viewed

Addressing Antimicrobial Resistance (AMR) Through Collaborative Efforts Fostering a Quality Culture in the Pharmaceutical Industry Advancements in Computer-Aided Drug Design for Pharmaceutical Research Why India is Gaining Popularity for Clinical Trials The Future of Kidney Transplants in India Usage of Conversational AI in the Health Insurance Sector Strategies for India to Reduce Its API Dependence on China Business Impact of USFDA Approvals on Indian Pharma Companies Innovative Strategies for Expanding Access to Life Saving Healthcare Solutions Badhal Village Crisis: How Rapid Diagnostics Could Have Saved Lives Why India is a Hotspot for Biotech Startups? Why Adapting Flexibility in IP Rights will Drive Generics Market Meeting the Challenges of High-Potency API (HPAPI) Production Impact of Human Factors Engineering on Medical Device Safety The Future of Pharma: Embracing Continuous Manufacturing The Role of Orphan Drugs in Treating Rare Diseases Emerging Technologies Shaping the Future of Drug Formulation Strategies for Optimizing Pharmaceutical Supply Chain Efficiency The Future of Medicine: Harnessing the Power of RNA-based Therapeutics AI in Medicine: Unmasking the Myths and Embracing the Transformative Reality Cycle Pharma Acquires Banner Life Sciences WHO's First-ever Global Summit on Traditional Medicine Starts in Gujarat The Importance of Data Integrity in Pharmaceutical Quality Control DCGI in Talks with Stakeholders to Develop a Standardised Web Platform to Assure Drug Quality and Patient Safety Glenmark Pharmaceuticals secures ANDA Nod for 0.03 per cent Tacrolimus Ointment Streamlining Laboratory Operations with a Modern LIMS Healthtech Start-up Suraksha QR Ropes In Actor Murali Sharma as its Brand Ambassador Unlocking the Potential of Pharmacogenomics: Enhancing Drug Safety and Efficacy The Impact of Pharmaceutical Testing on Drug Development India has Identified Three Health Priorities to Strengthen Global Health Infrastructure, says WHO National Health Authority launches 100 Microsites Project to Speed Up Digital Health Adoption India Should Partner with Australia to avail PBS for the Selection, Listing, and Pricing processes of exported drugs, says Sudarshan Jain Zydus Lifesciences India More than Doubles Profit Due to Increased Sales in the US India Triples Organ Donations over Past Decade says Union health minister Mansukh Mandaviya Advent Therapeutics Awarded $3 Million NIH Grant For Novel Neonatal Lung Therapy Three Pharma Marketing Strategies That Drive Sales Novartis Targets India's Rare Disease Market with 17 Clinical Programs UK Health Regulator approves GSK's Vaccine for the common respiratory virus RSV WHO Urges Increased Use Of Recommended Malaria-Fighting Tools Karnataka Budget Offered a Significant Boost to Health & Lifesciences Start-ups with Focus on Infrastructure & Innovation Three High Potential Moonshot Project Areas in Pharma CCI approves Bharat Biotech International-Eastman Exports deal How Biotech is Revolutionizing the Fight Against Cancer LifeCell and HaystackAnalytics ink strategic pact to scale-up TB whole genome sequencing pan-India Mankind Pharma IPO To Open On April 25 With A Price Fixed At Rs 1,026-1,080 Per Share US CDC Approves Second Omicron-Updated COVID Booster For Adults Three Trends that will Impact Pharmaceutical Industry in 2023 ModeX Therapeutics Commences Phase I EBV Vaccine Trial with Merck Designing Impactful Leadership and Talent Management Programs with Strategies for Success Novo Nordisk and Valo Health Partner to develop novel Treatments FOPE Calls for Extended Deadline for Schedule M Compliance Telix Pharma To Acquire ImaginAb to Boost Therapeutics and Innovation Roche Secures US FDA Approval for its Ultra-Sensitive ISH test Rappta Therapeutics and SpringWorks Partner on Molecular Glue Targeting PP2A Taro Pharma To Acquire entire stake in Antibe Therapeutics Innovent Biologics Secures Breakthrough Therapy Designation for IBI343 Emcure Pharma Launches Largest R&D Centre in Ahmedabad Zydus Bags USFDA Nod for Phase II(b) Trial to Optimize Usnoflast Dosage US FDA Approves Amgen's Lumakras-Vectibix Combo for KRAS G12C-Mutated mCRC Glenmark Pharma Unveils generic anticoagulant injectable emulsion Strides Pharma Bags USFDA Nod for OTC Acetaminophen-Ibuprofen Combo Tablets US FDA Lifts Hold on Sanofi's Trial to Make Cialis Available Over-the-Counter Hoth Therapeutics Expands Intellectual Property with New Patents Jaguar Health Starts POC Trial of Crofelemer for Rare Pediatric Disease MVID Pharma and Healthcare Sector Eyes Union Budget 2025 for Innovation Boost How Innovative Drug Formulations are Enhancing Treatment Outcomes Apollo and Mayapada Healthcare Unite to Boost Indonesia's Healthcare Novo Nordisk Reports Positive Phase 1b/2a Results for Amycretin Govt to Extend Schedule M Compliance Deadline for Drug Manufacturers to Dec Lupin Secures US FDA Nod for Ipratropium Bromide Nasal Solution ANDA Granules Pharmaceuticals Secures USFDA Nod for Key Generic Drug Bajaj Healthcare Bags DCGI Nod to Manufacture Pimavanserin API & Formulation Union Budget 2025: Healthcare Gets 9.78% Boost, Allocation Nears 1 Lakh Crore Metropolis & Roche Launch Self-Sampling HPV Test for Cervical Cancer Sigachi Industries Invests $1M in Hyderabad R&D Hub for API Innovation Pharma Testing Market Surges with Rising Demand for Biologics ISTH Releases Clinical Practice Guideline For Haemophilia Treatment Sanofi and Biovac Lead Polio Vaccine Manufacturing Capabilities Sun Pharma and Takeda Ink Pact To Market Gastrointestinal Drug Takeda and Ascentage Pharma Ink Option Agreement For Olverembatinib Enhancing Compliance through Effective Pharmaceutical Regulatory Affairs Strategies India poised to become a Global Hub for Clinical Trials: Exec SCHOTT Pharma Unveils Next-Gen Polymer Syringes for Enhanced Safety GSK's Jemperli Gains EU Nod for First-Line Treatment of Endometrial Cancer Union Health Secretary Urges Stronger Drug Regulations for Quality Control Telangana Govt Inks Landmark Deals to Propel Life Sciences and Job Growth R&D in Indian Pharma: Breakthroughs and Innovations in 2024 Dr. Reddy's Partners with Shanghai Henlius to Develop Cancer Drug Uniphar Expands Global Footprint with Three New Facilities 74th Indian Pharmaceutical Congress 2025 Opens Registrations AGC Pharma Expands HPAPI Capabilities in Barcelona to Meet Growing Demand The Future of Genomic Sequencing: Trends That Will Define the Next Decade Lexaria Bioscience Ethics Review Board Nod to Commence New GLP-1 Study Amitabh Kant Urges India to Focus on Innovation at BioAsia 2025 Government Enhances Research & Integration Initiatives in Unani Medicine Blind & Deaf individuals face Major Barriers to access Medicines: Report C-CAMP and PariSante Campus launched Indo-French Life Sciences Hub Jaguar Health Begins Pediatric Trial for Crofelemer in Short Bowel Syndrome Algiax Pharma Reports Promising Phase 2a Results for AP-325 Govt Bans 34 Antimicrobials for Use in Animals Pharmaceutical Procurement Strategies: How to Optimize Costs Personalized Medicine: Get Tailored Treatment Plans for You Now How to Bridge the Healthcare Gap in Emerging Markets with MedTech The Evolution of In-Vitro Diagnostics: Trends and Future Prospects Needle-Free Injection System: A Game Changer in Less Pain Vaccination How Global Capability Centers are Shaping the Future of Biometrics Building a Successful Pharma Brand in India: The Role of Scientific Communication Unlocking India's Innovation Potential in Pharma The Future of Green Chemistry in API Production Top 10 Pharmaceutical Recruitment Consultants - 2024 | Pharma Outlook Blockchain for Secure Pharmaceutical Supply Chains - 2025 & Beyond Mass Spectrometry in Biomarker Discovery for Early Disease Detection Iconovo and Lonza Team up to Advance Intranasal Biologic with ICOone Nasal Fetal Imaging to Cardiac Diagnosis: The Expanding Role of Ultrasound Balancing Innovation and Affordability in Medical Solutions for India Changing Landscape for LTBI and Syndromic Testing Methodologies How Advanced Training Methods can Enhance Patient Care Balancing Cost Efficiency and Compliance in Pharmaceutical Manufacturing LUB Urges Govt to Scrap Mandatory Lab Testing for Cough Syrup Exports Role of Optical Imaging in Early Cancer Detection and Treatment Hoth Therapeutics Unveils Promising Data for KIT-Targeting Therapy Pharmexcil Engages ASEAN Nations to Boost Pharma Trade Ties Fortis Partners with Teleflex for South Asia UroLift Training Anti-Infectives: How New Research is Shaping Infection Control Building Bridges for Sustainable Growth through Strategic Alliances in Ethical Pharmaceuticals Quality as the Cornerstone of Lab Solutions FDA Approves Roch's NSCLC Diagnostic Linked to Emrelis How Early Detection is Transforming Cancer Treatment in India Ensuring Data Privacy in Pharma World Enhancing Clinical Trial Supply Chain Resilience to Address Global Disruptions in India Cost-Effectiveness of Minimally Invasive Surgery in Outpatient Settings How Organic Synthesis is Accelerating Drug Discovery in Pharma Strategic finance for pharmaceutical innovation and stability Top 10 Teleradiology Service Providers - 2024 | Pharma Outlook Importance of Investing in R&D and Quality for Competitive Advantage in Eye Care Top 10 In Vitro Diagnostics Companies - 2024 | Pharma Outlook Phytopharmaceuticals: Driving Global Herbal Medicine Innovation Gender Gap in Healthcare: Why Women's Health Needs More Research Impact of Modern Technology on the Indian Life Sciences Sector Why Global Pharma Expects CDMOs to Be Ready for Joint Inspections The Role of Customizable Stent Grafts for Treating Complex Anatomies Nutraceuticals vs Pharmaceuticals: Complementary or Alternative in Chronic Disease Management? Top 10 Pharma CDMO Companies In India – 2023 | Pharma Outlook Leaping Towards Global Compliance with Revised Schedule M Meril Concludes TechVentory, Boosts AI-Driven Healthcare Supply Chains 10 Pharma Sector Revolutions in India Standardizing Medicine Labeling and Embracing Digital Transformation Creating a patient-centric healthcare ecosystem for all Biomanufacturing of Enzymes: A Sustainable Approach to Industrial Biotechnology Integrating CSR into HR Practices to Enhance Brand Reputation in Pharma Merck Launches Phase 3 Trial for Promising Dengue Vaccine V181 Breakthrough: Eye-Opening Healthcare Strategies Doctors Swear By on Doctor's Day 2025 Bristol Myers Squibb Reports Strong Phase 3 Results for Deucravacitinib trail Alcon Launches Innovative Daily Lenses Designed for Long-lasting Comfort Apisolex Excipient by Lubrizol Backs Phase I Drug Success FDA Approves Enflonsia to Prevent RSV in Infants with One Dose Biosimilars in India 2025 Market Trends, Growth Forecast & Opportunities How Regulations Are Shaping India's Medical Device Landscape Bharat Biotech Partners with GSK for Shigella Vaccine Development Eli Lilly Obesity Drug Shows 11.5% Weight Loss in 12 Weeks Laborate Pharmaceuticals: Illuminating Pathways Of Quality, Affordability Innovation In Healthcare Sun Pharma Bags CDSCO Approval to Produce Fexuprazan Hydrochloride Tablets The Fusion of Biology, Medicine, Health, and AI Glenmark Gets DCGI Nod to Launch Oncology Drug BRUKINSA in India Kyndryl Partners with Dr Reddys to Automate Global IT Operations How Robotic Assisted Surgery Is Redefining Precision in Kidney Transplants Top 10 Women Disruptors in Asia Pharmaceutical Industry

Related Articles


© 2026 India Pharma Outlook. All Rights Reserved.